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Abstract
Oxidative stress during myocardial reperfusion contributes to ventricular arrhythmias onset. We aim to evaluate the antiarrhythmic effect of Malbec wine and 
resveratrol and compare them with the synthetic antioxidant tiron. Since alcohol use is controversial, we also assessed dealcoholized wine.
Isolated hearts from male Sprague Dawley rats were perfused with Krebs-Henseleit solution added with: Malbec wine (5 ml/L), resveratrol (10 μM,) compared 
to controls with alcohol (0.5 ml/L); dealcoholized wine (5 ml/L), tiron (10 mM) were compared with controls without alcohol. Epicardial action potentials were 
analyzed during basal state, regional ischemia and reperfusion (10 minutes each period). The incidence of arrhythmias was determined. The antioxidant effect was 
assessed in left ventricle homogenates and expressed as a percentage of inhibition of the ABTS•+ radical.
Malbec wine and resveratrol reduced reperfusion arrhythmias in 56% and 50%, respectively, compared to 100% incidence in the control group with alcohol.
Dealcoholized wine reduced arrhythmias to 50% compared to non-alcoholic control (90.5%), but tiron did not protect (69%). The free radicals inhibitory effect 
increased with all the compounds (resveratrol 54.2%, tiron 43.2%, Malbec wine 42.9%, dealcoholized wine 40.2%) with respect to the control groups (with alcohol 
23.5%, without alcohol 21.2%). Resveratrol shortened action potential duration and prevented ischemic depolarization. Malbec prevented ischemic-induced action 
potential shortening.
We conclude that Malbec wine and resveratrol are antiarrhythmic beyond their antioxidant properties. Alcohol content or was not essential. Protection from ischemic 
action potential changes could be relevant to the antiarrhythmic effect of both resveratrol and wine.
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Introduction
Acute ischemic events are emergencies relevant for every 
physician [1]. The best and earliest treatment for myocardial ischemia 
is reperfusion [2]. However, during reperfusion, oxidative stress and 
metabolic/electrolyte imbalance contribute to ventricular arrhythmias 
onset [3]. Indeed, brief periods of ischemia and reperfusion due to 
coronary artery vasospasm could underlie sudden cardiac death [4,5].
Antioxidants are potential therapeutic strategies against 
cardiovascular diseases, including reperfusion injury [6–9]. Particularly, 
wine attracted much attention as cardioprotective due to the so-called 
French paradox [10–12]. Prospective studies suggest that wine is more 
protective against cardiovascular diseases than other alcoholic beverages 
like beer or liqueur [6,13,14]. Alcohol addictive properties and the 
damage associated with abuse make the wine difficult to recommend 
[15]. Besides alcohol, other components in wine support its protective 
properties [10,11,13,15,16]. However, the electrophysiological effects of 
wine are missing.
Resveratrol is one of the most studied wine components both 
in vivo and in vitro [12,17,18]. Clinical studies support discrete 
cardiovascular protection only after supplementation with high doses 
of resveratrol [19–21]. Its antioxidant, anti- inflammatory, fibrinolytic, 
and anti-atherogenic effects protect the endothelial organ [22–24]. 
High concentration of this stilbenoid is antiarrhythmic [25–30]. At 
micromolar concentrations, resveratrol inhibits voltage-sensitive 
calcium and potassium currents and activates ATP sensitive potassium 
channels (IKATP) [18,25,26,29–31].
We aim to evaluate the electrophysiological effects (action potentials 
and arrhythmias) of Malbec wine and resveratrol. To clarify the role of 
antioxidant properties as a potential antiarrhythmic mechanism, we 
compared them with the synthetic antioxidant tiron [32]. Since alcohol 
use is mechanistically and epidemiologically controversial, we also 
assessed dealcoholized wine.
Materials and methods
The animals were treated according to the local Committee on 
Ethics of Animal Experimentation recommendations, which are in 
agreement with the Guide for the Care and Use of Laboratory Animals 
as adopted and promulgated by the US National Institutes of Health.
Male Sprague Dawley rats weighing 260 to 320 g were used. Until 
euthanasia, animals were housed in metal cages with food and water at 
libitum and exposed to a cycle of 12/12h of light/darkness, respectively. 
After the deep anesthetic plane was achieved (by 80 mg/kg ketamine 
and 5 mg/kg xylazine i. p.), the hearts were removed and mounted on 
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the aortic cannula of the Langendorff perfusion setup in less than 3 
min. A modified Krebs-Henseleit (KH) perfusion solution contained 
(mM): 121 NaCl, 5 KCl, 2 CaCl2, 1.2 NaHPO4, 1.2 MgSO4, 25 NaHCO3 
and 10 glucose. The pH was 7,4 ± 0,05 when equilibrated with 5% CO2 
in O2, and temperature the perfusate was kept at 36 ± 0.5ºC.
Six experimental series were performed
1) Control: KH without additional components (n=21);
2) De-alcoholized Malbec, KH plus 5 ml/L of wine dealcoholized as 
described below (n=10);
3) tiron, 10 mM of the sintetic antioxidant (n=13);
4) Malbec, 5 ml/L of wine, (n=9) the composition of the Malbec is 
described below;
5) Resveratrol, 10 μM of resveratrol disolved in ethanol to final 
concentration of 0.5 ml/L, (n = 18)
6) Controls Alcohol, KH with the addition of 0.5 ml/L ethanol (n=12)
The Facultad de CienciasAgrarias (School of Agricultural Sciences, 
National University of Cuyo) provided the red wine from the Malbec 
grape variety. The characterization by high-performance liquid 
chromatography of Malbec was previously published [33]. The batch 
of Malbec wine contained 2.9 g/L of total phenols, 0.5 g/L of total 
anthocyanins and 3.8 g/l of total tannins. Resveratrol concentration 
was 1.1 mg/L. The other main components were (in mg/L): A) non-
flavonoids: 18.2 gallic acid; 2 caffeic acid; 4.2 cis- caftaric acid, B) 
flavonoids: 24.1 catechin; 14.2 epicatechin; procyanidin (11.3 B1; 3.1 
B3), C) flavonols: 4.9 quercetin, and D) anthocyanins: 344 malvidin-
3-glucoside; 16.2 peonidin-3-glucoside; 60.3 delphinidin-3-glucoside.
Malbec wine was dealcoholized by rotary evaporation at low 
temperature and pressure as previously described [34]. To conserve the 
phenolic composition, we added a volume of water according to the 
alcohol evaporated.
Although resveratrol was not the most abundant phenolic 
component in the wine, we decided to use it as the comparator 
because resveratrol is the best electrophysiologically characterized. The 
concentration used in this study is also in agreement with previous 
publication showing its cardioprotective properties [25–30]. Unless 
specified, all the other reagents were from Sigma-Aldrich (Saint Louis 
MO, USA).
After 20 min of equilibration, action potential and ECG were 
recorded during three periods of 10 minutes: basal state, ischemia (by 
anterior descending coronary artery occlusion with a 6/0 silk thread), 
and reperfusion. Ischemia and reperfusion were efficiently confirmed 
by coronary flow measurements. A reduction of 25% or more, after 
occlusion was corroborated in all the hearts.
Transmembrane potential was recorded glass microelectrodes 
(filled with 3 M KCl) from epicardial ventricular cells and synchronously 
displayed with the electrocardiogram (ECG), obtained with a 
positive electrode in the apex and the negative close the right atria. 
Microelectrodes (10 to 15 MΩ resistances) were amplified five times 
with custom-made equipment. Both signals were photographed from 
the screen of the oscilloscope (Tektronix 565) with a C4 Grass camera. 
The following action potential characteristics were measured: resting 
membrane potential (RMP), action potential amplitude (APA), and 
action potential duration at 90% of repolarization (APD90). The heart 
rate was measured from the ECG and the cell recordings. Arrhythmias 
were classified according to the Lambeth conventions [35]. A severity 
score of the arrhythmias was determined every minute. The values 
of the scale were: 0 sinus rhythm, 1 premature ventricular beats or 
bigeminy, 2 Salvos, 3 nonsustained ventricular tachycardia (<30 s), 4 
sustained ventricular tachycardia (>30 s), and 5 ventricular fibrillations. 
The hearts included in this study did not present sustained arrhythmias 
before reperfusion.
After of reperfusion, samples of 10 mg from the left ventricle free 
wall were transferred to Eppendorf tubes containing phosphate buffered 
saline, pH 7.4, and stored at -75ºC. All samples were homogenized 
keeping the temperature low by immersion of the tubes in ice 
during the process. The total antioxidant capacity was determined as 
previously described [36,37]. In brief, the radical ABTS•+, monocation 
of 2,29-azinobis-(3- ethylbenzothiazoline-6-sulfonic acid) is generated 
by ABTS oxidation with potassium persulfate and read at 600 nm 
with a UV-visible Spectrometer (Helios Gama, Helios Delta, Unicam 
instruments, UK), In the presence of hydrogen-donating antioxidants 
the cation is reduced and the color inhibited. The changes in the color 
induced by the samples were measured after 18 min of incubation 
at 37°C. The results are expressed as ABTS• + radical inhibition in 
percentage.
Data are expressed as means ± SEM. The results were analyzed with 
two-way ANOVA followed by the Student Newman Keuls posttest. The 
incidence of arrhythmias was tested with contingency tables using the 
Fisher exact test. The statistical level of significance was P<0.05.
Results
Arrhythmias
Brief ventricular tachycardia developed during the first seconds 
of flow restitution in control group regardless the presence of alcohol. 
One example of this arrhythmias is shown in Figure 1. In both control 
groups (with and without alcohol), the tachycardia persisted during 
reperfusion and alternated with episodes of ventricular fibrillation. The 
severity score of arrhythmias persisted high through the ten minutes 
evaluated (Figure 2).
Malbec wine prevented the onset of reperfusion arrhythmias 
(Figures 1 and 2). However, when arrhythmias developed in wine 
treated hearts, the severity persisted high like in the controls. Therefore, 
the severity score reflects the combination of hearts in sinus rhythm 
and hearts with sustained arrhythmias.
Resveratrol antiarrhythmic effect was like the one observed with 
Malbec wine. The hearts that suffered arrhythmias recovered sinus 
rhythm in less than 60 seconds. At the end of the ten minutes of 
reperfusion, the proportion of hearts without arrhythmias was the same 
that the Malbec group.
The synthetic antioxidant tiron did not reduce ventricular 
arrhythmias. Ventricular fibrillation developed during the first minute 
of reperfusion in most of the hearts and persisted during the following 
ten minutes.
Dealcoholized wine was as protective as Malbec and resveratrol. 
The preventive action was present in half of the hearts and persisted 
through the reperfusion period.
Action potentials
The morphology of action potentials during the different phases of 
the experiment showed the same pattern for both control groups (Figure 
3). Therefore, we decided to show representative traces from the control 
with alcohol group to compare them with Malbec and resveratrol-
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Figure 1. Representative action potentials and ECG from Control Alcohol, Malbec and Resveratrol groups. The columns indicate the experimental period; 1 and 9 correspond to the 
minute of reperfusion. The horizontal scale on the right corresponds to 0.5 seconds and the vertical scale correspond to 40 mV for action potentials and to 2 mV for ECG signal. Arrow in 
Control Alcohol during ischemia indicates the delay in activation and during reperfusion, the oscillation of membrane potential without reaching a resting state. Arrows during Resveratrol 
reperfusion indicate delay after depolarizations.
Figure 2. Reperfusion arrhythmias. Above is quantified the combined incidence of ventricular tachycardia and fibrillation Below is depicted the arrhythmic score observed minute-by-minute 
during reperfusion. *P<0.05 versus the corresponding control (either with or without alcohol).
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treated hearts (Figure 1). During the basal state, resveratrol shortened 
action potential duration during basal state, but resting potential and 
amplitude remained unchanged concerning Control. Malbec, tiron, 
and dealcoholized wine did not change the resting membrane potential, 
action potential amplitude, or duration of basal state recordings.
Action potentials from control hearts during ischemia showed 
resting membrane depolarization, an activation delay before the 
steepened depolarization (indicated by the arrow), a reduction of the 
amplitude and a shortening in action potential duration (Figure 1). 
Malbec wine with and without alcohol prevented the action potential 
shortening induced by ischemia (Figures 1 and 3). Resveratrol was the 
only treatment that preserved the resting potential during ischemia. 
Tiron did not modify the action potentials during ischemia.
During reperfusion, the number of action potentials to evaluated 
was reduced due to the presence of irregular rhythms, as can be seen in 
Figure 1. The membrane oscillation could be named afterdepolarizations, 
but the resting potential was not clear in many cases. Therefore, the 
values in Figure 3 only corresponds to action potentials of beats in sinus 
rhythm confirmed in the ECG signal.
Interestingly, resveratrol showed delay after depolarization during 
the first minutes of reperfusion (see arrows in Figure 1), but the lower 
resting potential probably prevented the membrane from reaching the 
threshold to start a new action potential.
In tiron hearts that were in sinus rhythm during reperfusion, the 
action potentials recovered to the values observed during the basal 
state.
Antioxidant
The addition of alcohol to the KH solution did not increase the 
antioxidant capacity of the ventricles (Figure 4). Tiron and dealcoholized 
Figure 3. Action potential variables during the three experimental periods. Resting membrane potential (RMP), action potential amplitude (APA) and action potential duration measured at 
90% of the repolarization (APD90). * P<0.05 versus the corresponding control (either with or without alcohol), # P<0.05 versus basal state values for the same group.
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Malbec increased the antioxidant power in the myocardial tissue when 
compared to the control group. Malbec also increased the antioxidant 
capacity respect to both control and control with alcohol groups. The 
most effective antioxidant in this study was resveratrol.
Heart rate and coronary flow
Heart rate was the same in all groups before ischemia (Table 1). 
During ischemia, heart rate decreases around 20 to 50 beats/min in all 
hearts. Values of heart rate from reperfusion are not shown due to big 
disparities caused by arrhythmias.
The coronary flow remained stable in all the hearts without 
difference between the treatments (Table 1). After coronary ligation, 
the flow decreased 30 to 50 % in all cases. Reversibility of this reduction 
confirmed that reperfusion was successfully achieved.
Discussion
This study describes antiarrhythmic properties of Malbec wine 
and confirms resveratrol ones [25–30]. The electrophysiological 
mechanisms were different between them. During ischemia, Malbec 
prevented action potential shortening, and resveratrol prevented 
resting depolarization. Out results with dealcoholized wine refute any 
contribution or interference of alcohol to wine electrophysiological 
effects. The lack of effect of antioxidant tiron questions the role of free 
radicals as the primary determinant of reperfusion arrhythmias.
To our knowledge, this is the first report of the direct antiarrhythmic 
effect of Malbec wine (both with and without alcohol). Epidemiological 
studies suggested that red wine consumption is associated with a 
reduction of mortality and morbidity from ischemic heart disease, 
but there is no direct evidence to support wine as antiarrhythmic 
[6,11,15,16,18].  The antiarrhythmic mechanisms of natural drugs are 
usually deductions based on physiopathological reasoning, in vitro 
determinations and theoretical conclusions [38]. Here we demonstrate 
action potential modification by wine as a plausible explanation for its 
antiarrhythmic action after ischemia/reperfusion in rat hearts. Since 
the changes observed with wine occurred during ischemia, further 
electrophysiological characterization by techniques like path clamp 
will be difficult. Reproducibility is a potential problem because wine 
composition changes over time due to the varietals and vinification 
[39–41]. Our results interpretation should be taken with caution 
because they were obtained in isolated hearts, without autonomous 
nervous system or hemodynamic stress. The translation to human 
arrhythmias is unknown, but rat and human electrophysiology are 
markedly different [42–44].
The electrophysiological characteristics of Malbec and resveratrol in 
ventricular myocytes may play an important role in its antiarrhythmic 
effects beyond its antioxidant and free radical scavenging actions. Tiron 
was as antioxidant as Malbec but failed to protect from arrhythmias 
or modified action potentials. The preventive effect of Malbec against 
action potential shortening during ischemia could homogenize 
repolarization and reduce the substrate for reentrance [45–47].  We 
have previous results that support the protective role of antiischemic 
modification with melatonin (also a wine constituent) [37,48]. Besides, 
the activation was not delayed (compare the delay indicated by the 
arrows in control hearts from Figure 1) during ischemia suggesting 
that conduction could be preserved. Resveratrol also preserved 
conduction during ischemia, but the main change observed was relative 
hyperpolarization. This could be attributed to the reported activation 
of IKATP channels [26,27,31,49–51]. During ischemia, this channel open 
do to ATP/ADP imbalance, oxidative stress and acidosis [46,52–54]. 
Indeed, hyperpolarization could counteract triggered arrhythmias 
originated from delay after depolarizations, because the membrane 
threshold is more difficult to reach.
Despite the beneficial effects of doses of red wine, it is a health risk 
due to liver damage and physical addiction [11,15]. The antiarrhythmic 
effect of dealcoholized wine could overcome the problems mentioned 
above. We have previously reported protective effects of dealcoholized 
red wine against vascular remodeling and metabolic syndrome [34]. 
Our results support the nutraceutical properties of dealcoholized wine 
[11]. Another non-alcoholic derivate from grapes, like pomace, also 
possesses cardioprotective potential [55].
We could not attribute our results to any specific component of 
wine. For example, resveratrol content of Malbec was one thousand 
times lower than the one in Resveratrol group [12,20,21,56]. Also, most 
of the electrophysiological properties describe until now were obtained 
above the micromolar concentration range of resveratrol [25–30]. These 
concentrations are impossible to be achieved by Malbec or any red 
wine consumption alone [12,33]. Catechin, melatonin, and quercetin 
are also wine components, but the effective concentrations are at least 
two orders of magnitude below the active electrophysiological levels 
[7,12,36,57–59].
Heart rate (beats/min) Coronary flow (ml/min) 
Group Before ligation Before reperfusion Before ligation During ligation Reperfusion
Control 275.7 ± 12.5 239.7 ± 10.4 # 15.0 ± 1.4 7.4 ± 1.4 # 14.3 ± 1.8
Dealcoholized Malbec 290.7 ± 13.0 223.5 ± 10.2 # 13.6 ± 0.8 6.9 ± 0.9 # 10.3 ± 1.6
Tiron 279.2 ± 14.4 236.7 ± 11.9 # 14.9 ± 1.5 7.5 ± 0.8 # 13.2 ± 1.9
Control Alcohol 270.7 ± 12.0 256.7 ± 11.9 # 17.6 ± 1.6 9.4 ± 0.9 # 14.1 ± 1.1
Malbec 291.2 ± 12.8 256.7 ± 11.9 # 13.4 ± 1.5 7.0 ± 1.2 # 14.2 ± 1.5
Resveratrol 298.1 ± 12.1 231.8 ± 12.4 # 15.2 ± 1.4 9.1 ± 1.0 # 15.4 ± 1.3
Table 1. Heart rate and coronary flow in the isolated rat heart subjected to regional ischemia and reperfusion.
Figure 4. Antioxidant effect of ventricular homogenates measured as percentage of 
inhibition of the ABTS•+ radical. ** P<0.01 and *** P<0.001 versus the corresponding 
control (either with or without alcohol).
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We conclude that Malbec wine is an antiarrhythmic as effective as 
resveratrol, beyond its antioxidant properties and unrelated to alcohol 
content. Protection from ischemic action potential shortening could be 
a relevant contributor to the antiarrhythmic effect of wine.
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